MP50-09 LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST REDUCE SERUM ADRENAL ANDROGEN LEVELS IN PROSTATE CANCER PATIENTS

MLA

Yasuhiro Shibata, et al. “Mp50-09 Luteinizing Hormone-Releasing Hormone Antagonist Reduce Serum Adrenal Androgen Levels in Prostate Cancer Patients.” Journal of Urology, vol. 195, Apr. 2016. EBSCOhost, https://doi.org/10.1016/j.juro.2016.02.443.

APA

Yasuhiro Shibata, Yoshitaka Sekine, Kazuhiro Suzuki, Yosuke Furuya, Takashi Nitta, Haruo Kato, Kazuto Ito, Hiroshi Matsui, Yoshiyuki Miyazawa, & Hidekazu Koike. (2016). Mp50-09 Luteinizing Hormone-Releasing Hormone Antagonist Reduce Serum Adrenal Androgen Levels in Prostate Cancer Patients. Journal of Urology, 195. https://doi.org/10.1016/j.juro.2016.02.443

Chicago

Yasuhiro Shibata, Yoshitaka Sekine, Kazuhiro Suzuki, Yosuke Furuya, Takashi Nitta, Haruo Kato, Kazuto Ito, Hiroshi Matsui, Yoshiyuki Miyazawa, and Hidekazu Koike. 2016. “Mp50-09 Luteinizing Hormone-Releasing Hormone Antagonist Reduce Serum Adrenal Androgen Levels in Prostate Cancer Patients.” Journal of Urology 195 (April). doi:10.1016/j.juro.2016.02.443.